Dr. Natalya Baltrukovich
Investment Manager
About me
| Team | Berlin Team, Investment comittee, Life Sciences & Chemistry |
| at HTGF since | 2023 |
CV
Dr. Natalya Baltrukovich has many years of professional experience in the life science sector and pharmaceutical industry in the areas of research, project management, business development, licensing, product launch, portfolio management, strategy development, supply chain management and strategic planning.
During her career, she managed numerous negotiations for collaborations and licensing deals with biotech and pharmaceutical companies, with the goal of expanding the product portfolio.
With a PhD in Biophysics and an MBA degree, she is curious and open-minded in her search for disruptive technologies and breakthrough innovations. One of her strengths is to combine scientific innovation with commercial potential.
She enjoys spending her free time hiking, biking and canoeing with her family and is an active member of HBA, Healthcare Businesswomens Association.
My success stories in the HTGF portfolio
Founded as N-Fix, Zymofix specializes in scaling the production of beneficial microorganisms by fermenting biomass residues. The company was supported in its pre-seed stage by biotope by VIB, which helped …
Carelane is a health tech startup focused on addressing the inefficiencies in clinical trials by integrating multiple essential functions into a single, streamlined system, thereby digitizing study protocols and processes. …
InCephalo develops exclusively local treatments for neurological diseases, with a focus on cancers in the brain (primary brain cancers as well as secondary brain cancers). The proprietary Compartment Lock technology, …
ActiTrexx GmbH is a spin-off from the University Medical Center Mainz and was founded in 2020. The company develops ATreg, a cell therapy based on activated regulatory T cells that …
Draupnir Bio is a spin out company, from Aarhus University and the Max-Planck Society and establishing itself at the forefront of protein degradation. Draupnir’s novel and proprietary platform technology is …
NovaPump GmbH is developing and realising a leading solution for a novel right ventricular assist device (RVAD) with clear USPs (the only percutaneous device with pulsatile support). NovaPump’s catheter-based heart …
Guided to exit
Recent posts
Zum Artikel
Social Media & contact
LinkedIn
Dr. Natalya Baltrukovich
Profil